Tabea Schneidewind - Concepedia

Author

Tabea Schneidewind

Also Known As

Schneidewind, Tabea, Tabea Schneidewind

Publications

206

Citations

H-Index

Concepts

All Affiliations

Tabea Schneidewind is an author at Max Planck Institute of Molecular Physiology specializing in medicine, drug discovery, and systems biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	172
2	Natural Sciences	2	2	91
3	Biochemistry	2	2	91
4	Cell Biology	2	2	75
5	Chemical Biology	1	1	24

Tabea Schneidewind

Publications

196

Citations

H-Index

Page 1

	Year	Citations
Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets Tabea Schneidewind, Alexandra Brause, Axel Pahl, ChemBioChem Drug TargetHit IdentificationUnbiased Morphological ProfilingMolecular BiologyMolecular Characterization	2020	67
The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype Tabea Schneidewind, Shobhna Kapoor, Guillaume Garivet, Cell chemical biology Signal TransductionMolecular PhysiologySignaling PathwayMedicineReceptor Tyrosine Kinase	2019	51
Combined morphological and proteome profiling reveals target-independent impairment of cholesterol homeostasis Tabea Schneidewind, Alexandra Brause, Beate Schölermann, Cell chemical biology OxysterolMedicineGeneticsOmicsLipoprotein Metabolism	2021	30
Chemical Genetics Reveals a Role of dCTP Pyrophosphatase 1 in Wnt Signaling Alexandra Friese, Shobhna Kapoor, Tabea Schneidewind, Angewandte Chemie International Edition	2019	24
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation Jana Flegel, Saad Shaaban, Zhi Jun Jia, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryClick ChemistryProteome ProfilingChemical Biology	2022	24

Page 1